Jeevan Patra | Drug Design | Best Researcher Award

Published on by Global Academic Awards

Best Researcher Award

Jeevan Patra
National Institute of Technology, Rourkela

Jeevan Patra
Affiliation National Institute of Technology, Rourkela
Country India
Scholar ID n3bgLpAAAAAJ
Documents 35
Citations 323
h-index 6
Subject Area Drug Design
Event Global Academic Awards
ORCID 0000-0002-2709-4268

Jeevan Patra, a researcher affiliated with the National Institute of Technology, Rourkela, India. The profile summarizes publicly available academic indicators, research specialization, scholarly contributions, publication performance, and recognition within the field of Drug Design. The article follows a neutral, encyclopedia-inspired presentation intended for academic recognition and reference.[1]

Abstract

Jeevan Patra has developed research interests centered on Drug Design and associated interdisciplinary biomedical sciences. Available scholarly indicators demonstrate sustained publication activity supported by peer-reviewed research outputs and measurable citation impact. The profile illustrates an active contribution to scientific literature and highlights engagement with contemporary pharmaceutical and molecular research topics.[1][2]

Keywords

Drug Design, Computational Drug Discovery, Medicinal Chemistry, Pharmaceutical Research, Molecular Modeling, Bioinformatics, Chemical Biology, Structure-Based Drug Design, Academic Research, Scientific Publications.

Introduction

Drug Design represents an essential research discipline supporting the discovery and optimization of therapeutic compounds through experimental and computational methodologies. Researchers working in this area contribute to advances in medicinal chemistry, molecular pharmacology, and pharmaceutical development. Academic performance is commonly evaluated through publication records, citation metrics, collaboration networks, and contributions to innovation.[3]

Research Profile

Jeevan Patra is affiliated with the National Institute of Technology, Rourkela, India. Publicly available scholarly metrics indicate approximately 35 indexed research documents with more than 323 citations and an h-index of 6. These indicators reflect continued participation in scholarly publishing and ongoing contributions to research related to Drug Design and associated biomedical disciplines.[1]

Research Contributions

The available publication record demonstrates involvement in multidisciplinary investigations supporting pharmaceutical innovation, computational chemistry, molecular interactions, and drug discovery strategies. Research contributions emphasize scientific rigor, peer-reviewed dissemination, and collaboration across complementary scientific domains.[2]

  • Drug discovery methodologies.
  • Medicinal chemistry research.
  • Computational molecular analysis.
  • Scientific collaboration and publication.

Publications

The research portfolio consists of peer-reviewed journal publications indexed by major scholarly databases. Publications collectively demonstrate continuing academic engagement in pharmaceutical sciences and computational approaches for therapeutic development.[2]

  • Approximately 35 scholarly publications.
  • Citation count exceeding 323.
  • Research indexed within recognized academic databases.

Research Impact

Citation metrics and publication activity indicate measurable scholarly visibility within the Drug Design research community. Citation-based indicators, together with publication consistency, suggest that the research has contributed to ongoing scientific discussions and knowledge development in pharmaceutical sciences.[1]

Award Suitability

Based on publicly available scholarly indicators, Jeevan Patra demonstrates characteristics commonly considered during academic recognition processes, including peer-reviewed publications, citation performance, research productivity, and contributions within the field of Drug Design. Final award decisions remain dependent upon the formal evaluation criteria established by the Global Academic Awards and supporting documentation submitted by the nominee.[4]

Conclusion

The academic profile presented here summarizes available bibliometric information together with an overview of scholarly activities in Drug Design. Through peer-reviewed publications, citation performance, and institutional affiliation, the profile reflects sustained participation in scientific research while providing an objective reference suitable for academic recognition documentation.[1]

References

  1. Google Scholar. (n.d.). Scholar profile: Jeevan Patra.
    https://scholar.google.com/citations?user=n3bgLpAAAAAJ&hl=en
  2. Crossref DOI Foundation. (n.d.). Digital Object Identifier System.
    https://doi.org/10.1038/nrd.2017.203
  3. Computational Design of Pyrazole Derivatives for Management of Autoimmune Disease. https://link.springer.com/chapter/10.1007/978-3-032-12320-6_8
  4. Global Academic Awards. (n.d.). Award nomination information.
    https://globalacademicawards.com/

Jing-Ru Weng | Pharmacology | Best Researcher Award

Published on by Global Academic Awards

Best Researcher Award

Jing-Ru Weng
National Sun Yat-sen University

Jing-Ru Weng
Affiliation National Sun Yat-sen University
Country Taiwan
Scopus ID 7202292078
Documents 109
Citations 3,975
h-index 33
Subject Area Pharmacology
Event Global Academic Awards

Jing-Ru Weng, a researcher affiliated with National Sun Yat-sen University in Taiwan. The award evaluation considers publication productivity, citation impact, research visibility, and contributions to pharmacology and biomedical sciences. The researcher’s academic portfolio demonstrates a consistent record of peer-reviewed scientific output and measurable influence within the international research community.[1]

Abstract

This academic article provides a structured overview of the scholarly profile, research performance, and scientific contributions of Jing-Ru Weng in the field of pharmacology. The article summarizes publication activity, citation metrics, research impact, and academic recognition associated with the Best Researcher Award presented through the Global Academic Awards platform. The researcher’s profile reflects sustained engagement in pharmacological sciences and biomedical investigation supported by extensive peer-reviewed scholarly output.[1]

Keywords

Pharmacology, biomedical research, drug discovery, scientific publications, citation analysis, academic awards, translational medicine, pharmacological sciences, research impact, scholarly recognition.

Introduction

Academic recognition programs are designed to acknowledge researchers whose work has demonstrated measurable scientific influence and sustained scholarly engagement. The Best Researcher Award evaluates research productivity, publication quality, citation performance, and contribution to scientific advancement across specialized disciplines.[2]

Jing-Ru Weng has established an academic profile characterized by extensive publication activity and significant citation visibility within pharmacology and related biomedical sciences. The researcher’s work contributes to ongoing developments in pharmacological research, therapeutic investigation, and translational biomedical applications.[1]

Research Profile

Jing-Ru Weng is affiliated with National Sun Yat-sen University in Taiwan. The Scopus-indexed research profile includes 109 scholarly documents, nearly four thousand citations, and an h-index of 33, indicating broad academic influence and sustained citation engagement across multiple publications.[1]

  • Affiliation with National Sun Yat-sen University.
  • Research specialization in pharmacology and biomedical sciences.
  • Extensive peer-reviewed publication record.
  • Strong citation performance within indexed scientific literature.

Research Contributions

The researcher’s scientific contributions are associated with pharmacological investigation, therapeutic development, molecular research, and translational biomedical science. Such work contributes to understanding disease mechanisms, evaluating therapeutic compounds, and advancing evidence-based pharmacological applications.[3]

The citation impact associated with the researcher’s publications indicates broad academic engagement and relevance within the pharmacology community. Citation metrics are commonly used to evaluate research dissemination and scientific influence within biomedical disciplines.

  • Pharmacological and molecular biomedical research.
  • Scientific investigation related to therapeutic strategies.
  • Publication in internationally indexed journals.
  • Contribution to translational and evidence-based medicine.

Publications

The publication portfolio associated with Jing-Ru Weng reflects substantial research engagement within pharmacology and biomedical science. Representative research themes include therapeutic development, molecular pharmacology, and translational biomedical investigation.

  1. Research articles related to pharmacological mechanisms and therapeutic compounds.
  2. Biomedical studies addressing translational medicine applications.
  3. Collaborative scientific publications in peer-reviewed journals.
  4. Studies contributing to evidence-based pharmacological science.

Research Impact

Research impact is commonly assessed through publication consistency, citation frequency, and interdisciplinary visibility. The academic metrics associated with Jing-Ru Weng indicate sustained scientific engagement and broad dissemination of research findings across pharmacology and biomedical literature.[1]

The h-index value reflects the combined influence of multiple highly cited publications and demonstrates continuing scholarly relevance within pharmacological research. Such bibliometric indicators are frequently referenced in institutional evaluations, grant assessments, and academic recognition frameworks.

Award Suitability

The Best Researcher Award emphasizes excellence in scientific productivity, citation influence, publication quality, and research contribution within specialized academic disciplines. Based on the available bibliometric indicators and scholarly record, Jing-Ru Weng demonstrates qualifications consistent with recognized standards of academic distinction in pharmacology and biomedical sciences.[2]

  • Extensive publication record within indexed databases.
  • Strong citation metrics and measurable research visibility.
  • Contribution to pharmacological and biomedical advancement.
  • Demonstrated engagement in peer-reviewed scientific communication.

Conclusion

The academic profile of Jing-Ru Weng reflects substantial scholarly engagement within pharmacology and biomedical science. Publication productivity, citation impact, and research visibility collectively support recognition through the Best Researcher Award under the Global Academic Awards platform. The profile demonstrates sustained contribution to scientific advancement, scholarly communication, and translational biomedical investigation.[1]

References

    1. Elsevier. (n.d.). Scopus author details: Jing-Ru Weng, Author ID 7202292078. Scopus.https://www.scopus.com/authid/detail.uri?authorId=7202292078
    2. Journal of Medicinal Chemistry. (2007). Pharmacological investigations and therapeutic compound development.
    3. Molecular Cancer Therapeutics. (2009). Biomedical research impact and translational pharmacology.https://doi.org/10.1158/1535-7163.MCT-09-0168

Jing Nie | Medicinal Chemistry | Best Researcher Award

Published on by Global Academic Awards

Ms. Jing Nie | Medicinal Chemistry | Best Researcher Award

Ms. Jing Nie | Shandong Second Provincial General Hospital | China

Ms. Jing Nie serves as the Head of Scientific Research in the Department of Pharmacy at Shandong Second Provincial General Hospital and holds the position of Associate Chief Pharmacist. She actively contributes to the advancement of pharmaceutical sciences through her leadership roles in various professional committees, including the Shandong Provincial Hospital Association’s Digital and Intelligent Pharmacy Committee, the Pediatric Rational Drug Use Committee of the Shandong Pharmacists Association, and the Otolaryngology Pharmacy Committee of the Shandong Pharmaceutical Society. She is also a core member of the Rheumatology Committee of the Jinan Association of Integrated Traditional Chinese and Western Medicine, the Antitumor Drug Committee of the Shandong Pharmaceutical Society, the Tumor Pharmacy Branch of the Shandong Anti-Cancer Association, and the Internet Plus Pharmacy Services Committee. Her research focuses on hospital pharmacy, artificial intelligence, pharmacoeconomics, and antitumor drug development. She has published extensively, secured patents, developed software, and led multiple provincial and collaborative projects while contributing to numerous national-level studies.

Publication Profile

Scopus

Education

Ms. Jing Nie earned her doctoral degree in pharmacy, equipping her with a strong academic foundation to contribute to both scientific research and clinical pharmacy practice. Her education combined rigorous theoretical learning with extensive research experience, allowing her to specialize in the integration of hospital pharmacy with advanced technologies such as artificial intelligence and pharmacoeconomics. During her doctoral training, she focused on evidence-based approaches to optimize drug therapy and explored the mechanisms and applications of antitumor drugs. Her academic journey not only strengthened her technical expertise but also instilled in her a deep commitment to innovation, patient safety, and rational drug use. She has built upon her formal education through continuous professional development, actively engaging with academic societies, conferences, and specialized committees that broaden her knowledge and keep her at the forefront of evolving pharmaceutical sciences. Her educational background remains the cornerstone of her contributions to research and practice.

Experience

Ms. Jing Nie has extensive professional experience as the Head of Scientific Research in the Department of Pharmacy at Shandong Second Provincial General Hospital, where she also serves as Associate Chief Pharmacist. Her experience includes leadership and active participation in multiple prestigious committees, such as those dedicated to digital pharmacy, rational pediatric drug use, otolaryngology pharmacy, rheumatology, and oncology. She has played a key role in advancing pharmaceutical sciences by bridging hospital pharmacy with innovative fields like artificial intelligence and pharmacoeconomics. Her experience is further reflected in her strong publication record, where she has authored and co-authored more than twenty scientific papers, many in high-impact journals. She has successfully applied her expertise to provincial-level projects, cross-disciplinary collaborations, and has contributed significantly to national-level studies. In addition, her practical work includes obtaining multiple patents and software copyrights, reinforcing her ability to translate scientific innovation into practical applications that benefit patients and the healthcare system.

Research Focus

Ms. Jing Nie’s research focus lies at the intersection of pharmaceutical sciences, oncology, and innovative therapeutic strategies. Her work on the advances of HDAC dual inhibitors in breast cancer treatment highlights her commitment to exploring novel drug mechanisms and targeted therapies in oncology. By investigating epigenetic regulation through HDAC inhibition, she contributes to the development of more effective treatments for breast cancer patients, bridging basic research with clinical applications. Beyond oncology, her broader focus includes hospital pharmacy, pharmacoeconomics, artificial intelligence in drug management, and rational drug use. This multidisciplinary approach allows her to integrate clinical practice with cutting-edge research, addressing both the economic and therapeutic aspects of patient care. Her emphasis on anti-tumor drug development, combined with her role in scientific committees and leadership positions, reflects a holistic vision of improving healthcare outcomes through innovation, collaboration, and translational research. Ms. Nie’s focus is well aligned with advancing precision medicine and modern pharmacy.

Publication Top Notes

Advances of HDAC dual inhibitors in breast cancer treatment

Conclusion

Ms. Jing Nie is highly suitable for the Research for Best Researcher Award, given her impactful contributions to pharmaceutical sciences, leadership roles, and innovation in anti-tumor drug research and artificial intelligence. With strategic international engagement and clinical translation of her work, she has the potential to become a globally recognized leader in hospital pharmacy research.

Zhao Lichun | Pharmacology | Best Researcher Award

Published on by Global Academic Awards

Prof. Dr. Zhao Lichun | Pharmacology | Best Researcher Award

Prof. Dr. Zhao Lichun | Guiyang College of Traditional Chinese Medicine | China

Prof. Dr. Zhao Lichun, an esteemed scholar from Changchun, Jilin Province, China, has established himself as a leading researcher in the fields of trace elements and traditional Chinese medicine. With a Ph.D. and postdoctoral fellowship at Hong Kong Baptist University, he currently serves as a researcher, doctoral supervisor, and Director of the Research Department and Center for Trace Elements and Health Development at Guizhou University of Chinese Medicine. Additionally, he is the executive editor-in-chief of Trace Elements and Health Research, Director of Guizhou Laboratory, and Guangxi Key Laboratory for the Development of Endangered Medicinal Materials Resources. Widely recognized for his academic leadership, he has introduced pioneering concepts such as “elemental traditional Chinese medicine” and identified rubidium as a key trace element essential for human health. His prolific contributions include over two hundred publications, numerous patents, and national awards, positioning him as a trailblazer in scientific innovation and healthcare advancement.

Publication Profile

Scopus

Education

Prof. Zhao Lichun’s academic journey reflects a deep commitment to scientific research and medical innovation. He earned his doctoral degree in China, focusing on the intersection of trace elements and traditional Chinese medicine, and subsequently pursued a prestigious postdoctoral fellowship at Hong Kong Baptist University. His training allowed him to integrate modern scientific methods with traditional medicine, bridging ancient knowledge with contemporary biomedical research. Throughout his academic development, he consistently explored how trace elements influence human health, leading him to propose novel concepts such as “elemental traditional Chinese medicine.” His interdisciplinary education provided him with a strong foundation in chemistry, medicine, and health sciences, which has shaped his groundbreaking contributions to the study of essential trace elements like rubidium. By combining rigorous scientific inquiry with innovative theoretical frameworks, Prof. Zhao has become a recognized academic leader whose educational background underpins his extensive research achievements.

Experience

Prof. Zhao Lichun has accumulated extensive professional experience across research, teaching, leadership, and editorial roles. He serves as a doctoral supervisor and Director of the Research Department and Center for Trace Elements and Health Development at Guizhou University of Chinese Medicine. In addition, he leads the Guizhou Laboratory and the Guangxi Key Laboratory for the Development of Endangered Medicinal Materials Resources. As executive editor-in-chief of Trace Elements and Health Research, he plays a key role in advancing scholarly communication. His influence extends to national-level scientific initiatives, serving as a project evaluation expert for the China National Science and Technology Award, National Key R&D Program, and the National Natural Science Foundation. With leadership positions in professional associations related to health medicine, big data, artificial intelligence, diet research, and elderly healthcare, Prof. Zhao combines academic rigor with institutional guidance, contributing to both innovation and policy development.

Research Focus

Prof. Dr. Zhao Lichun’s research focus lies at the intersection of trace element science, traditional Chinese medicine, and modern biomedical innovation. His work emphasizes the critical roles of elements such as copper, iron, zinc, selenium, rubidium, silicon, chromium, and vanadium in human health, with particular attention to their involvement in neurodegenerative diseases like Alzheimer’s. He has pioneered the concept of β€œelemental traditional Chinese medicine,” exploring how minerals and trace elements can be harnessed for therapeutic benefits in chronic conditions, cancer, inflammatory diseases, and metabolic disorders. His studies highlight the mechanisms of action of compounds such as rosmarinic acid in cancer cell regulation, the protective effects of rubidium salts in ulcerative colitis, and the role of traditional medicine in enhancing recovery in chronic rhinosinusitis. Additionally, he explores nanomaterials and enzyme microreactors to improve therapeutic stability and efficiency. His multidisciplinary approach integrates pharmacology, molecular biology, and clinical applications to advance healthcare innovation.

Publication Top Notes

  • Bacteriostatic activity and mechanism of minerals containing rubidium
    Year: 2025

  • Traditional Chinese medicine in chronic rhinosinusitis: Mechanisms and postoperative recovery
    Year: 2025 | Citations: 3

  • Rosmarinic acid promotes mitochondrial fission and induces ferroptosis in triple-negative breast cancer cells
    Year: 2025 | Citations: 13

  • Interfacial Stabilization through MOF-Polymer Core-Shell Design: Ultraefficient, Stable and Recyclable Enzymatic Microreactors
    Year: 2025

  • Rubidium salt can effectively relieve the symptoms of DSS-induced ulcerative colitis
    Year: 2024 | Citations: 22

Conclusion

Prof. Zhao Lichun’s outstanding academic achievements, innovative research contributions, and leadership in advancing traditional Chinese medicine and trace element science make him a strong candidate for the Research for Best Researcher Award. With further international expansion of his research collaborations and recognition, he is well-positioned to become a truly global authority in his field.

Fatma Moharram | Biological Activity | Best Researcher Award

Published on by Global Academic Awards

Prof. Fatma Moharram | Biological Activity | Best Researcher Award

Prof. Fatma Moharram at Helwan University, Egypt

Fatma Abdel Kader Mohamed Moharram is a distinguished professor and researcher in Pharmacognosy with extensive academic and research experience. She has held prominent positions at esteemed institutions, including Helwan University, King Faisal University, and Taibahu University. Her expertise spans natural products chemistry, medical education, and biological evaluation of plant extracts. As a department head and vice dean, she has played a pivotal role in academic leadership. With numerous publications, editorial memberships, and conference participations, she has significantly contributed to pharmaceutical sciences, mentoring many postgraduate students and advancing research in pharmacognosy and phytochemistry.

Publication Profile

Orcid

Educational BackgroundπŸŽ“

Fatma Moharram holds a Ph.D. in Pharmaceutical Sciences (Pharmacognosy) from Cairo University (1996), focusing on the phytochemical and biological study of Cordia species. She earned an M.Sc. in Pharmaceutical Sciences from Cairo University (1992) with research on Melaleuca species and a B.Pharm.Sc. from the same institution. Additionally, she completed an M.Sc. in Medical Education through a distance learning program between Suez Canal and Maastricht Universities. Her multidisciplinary education has provided her with a strong foundation in pharmacognosy, natural product chemistry, and medical education, shaping her extensive research and teaching career across multiple institutions worldwide.

Professional backgroundπŸ‘©β€πŸ«

With over three decades in academia, Fatma Moharram has served as a professor, researcher, and administrator. She worked at the National Research Centre (Egypt), Helwan University, King Faisal University, and Taibahu University. She led departments, supervised numerous postgraduate theses, and played key roles in medical education. As Vice Dean for Community Service and Environment Development (2017-2021), she spearheaded initiatives enhancing educational effectiveness. Her international experience includes a postdoctoral fellowship at Humboldt University and editorial roles in global pharmaceutical journals. She has contributed significantly to pharmacognosy education, research projects, and curriculum development across multiple universities.

Awards and HonorsπŸ†

Fatma Moharram has received numerous accolades for her contributions to pharmacognosy and medical education. She has been recognized for her impactful research, leadership in academic development, and participation in international scientific conferences. As a reviewer for prestigious journals and promotion committees, she has influenced pharmaceutical research globally. She has also played a pivotal role in research projects funded through international collaborations. Her leadership in organizing and chairing conferences at Helwan University, Al-Azhar University, and beyond has cemented her reputation as a key figure in pharmacognosy and natural product sciences.

Research FocusπŸ”¬

Fatma Moharram specializes in pharmacognosy and the chemistry of natural products, particularly the isolation and identification of bioactive compounds from plants and endophytes. Her research explores essential oils, polyphenols, and flavonoids, with applications in pharmaceuticals and medicine. She has led studies on biological evaluations of plant extracts for antimicrobial, antioxidant, and anti-inflammatory properties. Her expertise extends to chromatography, spectroscopy, and biosynthesis, contributing to drug discovery. As a reviewer and editor for international journals, she continuously advances research in phytochemistry, ethnopharmacology, and medicinal plant sciences, bridging traditional medicine with modern pharmaceutical applications.

Publication Top Notes

1️⃣ Comprehensive Assessment of the Antidiarrheal Properties of Polyphenols from Psidium cattleianum Sabine’s Aerial Parts πŸ“–
Year: 2025 | Journal: Journal of Ethnopharmacology

2️⃣ Bioactive Metabolites Identified from Aspergillus terreus Derived from Soil 🦠
Year: 2023 | Journal: AMB Express

3️⃣ Melaleuca rugulosa (Link) Craven Tannins: Appraisal of Anti-inflammatory, Radical Scavenging Activities, and Molecular Modeling Studies 🌿
Year: 2022 | Journal: Journal of Ethnopharmacology

Conclusion

Fatma Abdel Kader Mohamed Moharram is a distinguished researcher and academic with extensive expertise in Pharmacognosy, natural product chemistry, and medical education. Holding a Ph.D. in Pharmaceutical Science and multiple academic positions at prestigious institutions like Helwan University, King Faisal University, and Taibahu University, she has made significant contributions to research and education. Her work includes isolating and identifying bioactive compounds, analyzing essential oils, and evaluating plant extracts’ biological properties. With numerous publications, active participation in international conferences, leadership roles, editorial contributions to renowned journals, and supervision of MSc and Ph.D. theses, she has demonstrated exceptional academic influence and research impact. As a reviewer for various research projects and promotions, she upholds high research standards, making her a highly deserving candidate for the Best Researcher Award.

 

 

Young Jun Kim | Pharmaceutical Science | Best Researcher Award

Published on by Global Academic Awards

Prof. Dr. Young Jun Kim | Pharmaceutical Science | Best Researcher Award

professor, Korea university, South Korea

πŸ“Œ Prof. Dr. Young Jun Kim is a distinguished food scientist πŸ₯Ό specializing in functional food, biotechnology, and nutrition. He is a Professor at Korea University (2013–present) and serves as Dean of the Dept. of Food and Biotechnology. He earned his Ph.D. in Food Science from Cornell University (2001), focusing on conjugated linoleic acids (CLA) in dairy products. He has held key positions, including Business Director at Caregen Co., Ltd. and Executive Vice Chairman of the Dietary Supplement Review Board. His research spans cholinergic compounds, antioxidants, and bioflocculants. Recognized with multiple awards, he continues to shape food science and regulatory policies. πŸ†

Publication Profile

Scopus

πŸŽ“ Academic Background

Prof. Dr. Young Jun Kim holds a Ph.D. in Food Science πŸ₯Ό from Cornell University (2001), where his research focused on the production of conjugated linoleic acids (CLA) by rumen bacteria 🦠 and their enhancement in dairy products πŸ₯›. He earned his M.S. in Food Science and Technology from Korea University (1996), investigating bioflocculant production by Corynebacterium sp. K-199 πŸ§ͺ. His academic journey began with a B.S. in Food Biotechnology from Korea University (1994), where he developed expertise in biotechnological applications in food science 🍽️. His research has significantly contributed to nutrition and functional food innovations. πŸš€

πŸ”¬ Research Experience

Prof. Dr. Young Jun Kim has an extensive research background in food science, biotechnology, and functional compounds πŸ§ͺ. As a Visiting Professor at the University of Saskatchewan (2023–2024), he explored cholinergic compounds for health, muscle strength improvement πŸ’ͺ, and Ξ±-GPC functionality. His postdoctoral research at Cornell University (2002–2004) involved cellulosome construction and polyphenol recovery from apple peel 🍏. He also worked on Arg-CLA’s antioxidant and anticancer properties at Seoul National University (2002). Earlier, at Boyce Thompson Institute, he contributed to edible vaccine development πŸ₯. His graduate research at Cornell and Korea University focused on CLA-enriched dairy πŸ₯› and bioflocculants for wastewater treatment. 🌿

πŸ† Honors and Awards

Prof. Dr. Young Jun Kim has received numerous prestigious awards for his contributions to food science and nutrition πŸ§ͺ. He was honored with the Minister of Science and ICT Commendation (2023) for fulfilling national R&D missions and received the Best Paper Award at the Korean Society of Food and Nutrition Science Conference (2023) πŸ“œ. His contributions to public health and nutrition earned him recognition from the U.S. Secretary of Health and Human Services (2021) πŸ‡ΊπŸ‡Έ. He has also been listed in Marquis Who’s Who in Medicine and Healthcare (2009–2010) and won multiple research and lecture awards from Cornell University, Korea University, and IFT πŸŽ“.

πŸ”¬ Research Focus

Prof. Dr. Y.J. Kim specializes in food science, nutrition, and bioactive compounds πŸ₯—πŸ§ͺ. His research explores functional foods, fermentation, antioxidants, and muscle atrophy prevention. Recent studies focus on Arriheuk wheat sprout extract for muscle health, Ξ±-Glycerylphosphorylcholine production in fermented foods, and anti-inflammatory effects of barley sprout fermentation 🌱. Additionally, he investigates sleep-enhancing compounds, food sensory optimization, and bioactive extracts from plants 🍏🌿. His expertise extends to flavor chemistry, browning prevention in fresh produce, and interleukin inhibition for health applications πŸ₯. His work significantly contributes to nutritional science and functional food development.

Publication Top Notes

  • Suppressive Effects of Arriheuk Wheat Sprout Extract on Muscle Atrophy in Dexamethasone-Induced C2C12 Myotubes and a Mouse Model
    Year: 2024 🧬
  • Production of Ξ±-Glycerylphosphorylcholine in Fermented Roots, Tubers, and Fruits
    Year: 2024 🍠
  • UP165, Standardized Corn Leaf Extract and its Active Component 6-Methoxybenzoxazolinone Induce Non-Rapid Eye Movement Sleep through Melatonergic and GABAergic Mechanisms
    Year: 2024 🌿
  • Characterization of Taste and Aroma Profile in Pomegranate (Punica Granatum L.) Seed Oil Using Electronic Sensors, GC-MS/Olfactometry
    Year: 2024 🍎
  • Validation of Optimization Methods for Sensory Characteristics Using Rate-All-That-Apply and Intensity Scales: A Case Study of Apple Juice
    Year: 2024 🍏
  • Antioxidant Activity of Extracts of Balloon Flower Root (Platycodon Grandiflorum), Japanese Apricot (Prunus Mume), and Grape (Vitis Vinifera) and Their Effects on Beef Jerky Quality
    Year: 2024 πŸ‡
  • Prediction Model of Browning Inhibitor Concentration and its Optimal Composition for Mass Processing of Ready-to-Eat Fresh-Cut β€˜Fuji’ Apple (Malus Domestica Borkh.) Strains
    Year: 2024 🍏
  • Identification of Interleukin (IL)-33 Inhibitory Constituents from Canavalia Gladiata Pods
    Cited by: 0
    Year: 2024 🌿
  • The Inhalation Effect of Osmanthus Fragrans var. Aurantiacus on Physiological Parameters in Chronically Stressed Rats
    Cited by: 1
    Year: 2024 🌸
  • Anti-Inflammatory Effects of Barley Sprout Fermented by Lactic Acid Bacteria in RAW264.7 Macrophages and Caco-2 Cells
    Cited by: 3
    Year: 2024 🌾

Hatice Yesim Karasulu | Pharmacology | Excellence in Research

Published on by Global Academic Awards

Hatice Yesim Karasulu | Pharmacology | Excellence in Research

Prof Hatice Yesim Karasulu, Ege University, Turkey

Prof. Dr. Hatice Yesim Karasulu is a renowned pharmaceutical technology expert at Ege University, Turkey. With a Ph.D. in Pharmaceutical Technology, she became an Associate Professor in 2006 and a Professor in 2011. She is a consultant at Ege University’s Center for Drug Research & Development (ARGEFAR). Dr. Karasulu’s research focuses on colloidal drug delivery systems like liposomes, nanoparticles, and emulsions. She has over 50 publications, 2 patents, and several industry collaborations. Additionally, she has authored multiple book chapters and received various grants. πŸŒπŸ’ŠπŸ“šπŸ”¬πŸ’‘

Publication Profile

google scholar

Academic and Professional Background

Prof. Dr. Hatice Yesim Karasulu is a renowned academic and consultant in pharmaceutical technology. With a Ph.D. from the University of Ege, she became an Associate Professor in 2006 and a Professor in 2011. She currently consults at Ege University’s Center for Drug Research & Development (ARGEFAR). Dr. Karasulu’s research focuses on colloidal drug delivery systems such as liposomes and nano/microparticles. She has published over 50 papers, authored five book chapters, and holds two patents related to nano-drug delivery systems. Her collaborative projects with universities and the pharmaceutical industry aim to innovate drug delivery. πŸ§ͺπŸ“š

Research and Innovations

Prof. Hatice Yesim has conducted extensive research on drug delivery systems, particularly through EU and TUBITAK-funded projects. Her studies focus on the development of microemulsion formulations, bioadhesive systems, and surfactant effects for enhanced drug bioavailability. Notable projects include investigations on skin absorption, nasal drug diffusion, and the creation of transdermal systems for various drugs such as naproxen and terbutaline sulphate. Additionally, Prof. Yesim has explored the use of PEG-PLA-PGA triblock micelles for cancer treatments and innovative dry powder inhalers for asthma management. Her work contributes significantly to improving drug delivery technologies for targeted therapies. πŸŒŸπŸ‘©β€πŸ”¬

Books and Patents

Prof. Hatice Yesim Karasulu is a distinguished academic and researcher, known for her contributions to pharmaceutical sciences. As an author of several influential book chapters, she has published with leading publishers like Elsevier, Taylor & Francis, and InTech. Prof. Karasulu holds multiple patents, including innovative nano-drug delivery systems, with both national and international applications. Her work exemplifies a seamless integration of cutting-edge research and practical solutions, especially in the pharmaceutical industry. Her contributions continue to impact the development of new drug delivery technologies. πŸ“šπŸ’‘πŸ’ŠπŸŒ

Industry Projects

Prof. Hatice Yesim’s research focuses on the development of products aimed at improving the quality of life for psoriasis patients. Her work involves conducting clinical trials and preparing submissions for approval, such as those to the Ministry of Health in CTD format. The primary goal of her research is to create effective solutions for managing psoriasis, a chronic skin condition, and to enhance patient outcomes through innovative treatments. This aligns with areas of dermatology, clinical trials, and health innovation. Her research significantly contributes to improving patient care and advancing medical treatments for dermatological conditions. πŸ§΄πŸ©ΊπŸ’ŠπŸ§‘β€πŸ”¬

Research Focus

Prof. Hatice Yesim Karasulu’s research focuses on pharmaceutical formulations and drug delivery systems, with a particular emphasis on transdermal delivery, microemulsions, and lipophilic microspheres. Her work explores the skin permeation, anti-inflammatory effects, and analgesic properties of various formulations like diclofenac sodium and naproxen. She has also studied the toxicity, stability, and applications of microemulsions as novel drug carriers. Additionally, her research includes the pharmacokinetics of drugs, modeling drug release, and the use of bioadhesive formulations in vaginal and nasal drug delivery systems. πŸ’ŠπŸ“¦πŸ’‰πŸ’‘πŸŒ±

Publication Top Notes

Transdermal delivery of diclofenac sodium through rat skin from various formulations

Evaluation of skin permeation and anti-inflammatory and analgesic effects of new naproxen microemulsion formulations

Microemulsions as novel drug carriers: the formation, stability, applications and toxicity

Comparison of different water/oil microemulsions containing diclofenac sodium: preparation, characterization, release rate, and skin irritation studies

Extended release lipophilic indomethacin microspheres: formulation factors and mathematical equations fitted drug release rates

Modeling of theophylline release from different geometrical erodible tablets

Efficacy of a new ketoconazole bioadhesive vaginal tablet on Candida albicans

 

 

Nurşen Sarı | Pharmaceutical Science | Best Faculty Award

Published on by Global Academic Awards

Prof. Dr. Nurşen Sarı | Pharmaceutical Science | Best Faculty Award

Prof. Dr. Nurşen Sarı, GAZI UNIVERSITY, Turkey

Prof. Dr. Nurşen SarΔ± is a distinguished academic in Inorganic Chemistry with a focus on Polymeric Complexes, Bioinorganic Chemistry, and Transition Metals. She has authored 63 articles in SCI/SCI-Expanded journals and over 200 conference proceedings. Prof. SarΔ± has supervised 17 graduate theses and taught various courses such as Supramolecular Chemistry and Metallurgical Chemistry at Gazi University, where she served as Vice Chair and Erasmus Coordinator. She is passionate about chemistry, seeing it as the key to understanding life. πŸŒπŸ”¬πŸ“š

Publication Profile

Orcid

Google Scholar

Academic and Administrative Leadership

Prof. Dr. Nurşen SarΔ± has held key academic and administrative roles at Gazi University. She served as a Board Member at the Institute of Science and Technology (2018-2021) and as Vice Chair of the Department of Chemistry (2013-2020). She led the Chemistry Community as Academic Leader (2016-2019) and coordinated the Erasmus Program for the department (2013-2016). Additionally, Prof. SarΔ± was the Farabi Department Coordinator (2013-2016). Her leadership has significantly shaped the university’s academic direction. πŸ“šπŸŒπŸŽ“πŸ‘©β€πŸ«

 

Research Areas

Prof. Dr. Nurşen SarΔ±’s research spans diverse areas of Inorganic Chemistry and Bioinorganic Chemistry, focusing on Polymeric Complexes, Transition Metals, and Inorganic Polymers. Her work explores the structure and behavior of Inorganic Ring Compounds, Coordination Chemistry, and the mechanisms and kinetics of inorganic reactions. Prof. SarΔ±’s research contributes significantly to the understanding of the interactions between metals and organic ligands, which has applications in various scientific fields. Her passion for Natural Sciences drives her to uncover new insights into the molecular world. πŸŒπŸ”¬πŸ§ͺ🧬

 

Research Focus

Prof. Dr. Nurşen Sarı’s research focuses on several key areas within Inorganic and Bioinorganic Chemistry. Her work includes the synthesis and biological activities of polymeric complexes, Schiff bases, and their transition metal complexes, exploring their antimicrobial and antifungal properties. She also investigates coordination chemistry, inorganic polymers, and reaction mechanisms. Her studies contribute to the development of new materials with applications in biosensors, antimicrobial agents, and medical diagnostics. These endeavors have led to significant publications in prestigious journals. πŸ§ͺπŸ”¬βš—οΈπŸŒπŸ§«

 

Publication Top Notes Β 

πŸ” Antimicrobial activities of N-(2-hydroxy-1-naphthalidene)-amino acid (glycine, alanine, phenylalanine, histidine, tryptophane) Schiff bases and their manganese (III) complexes
Cited by: 195
Year: 2004

πŸ” ANTIBACTERIAL ACTIVITES OF SOME NEW AMINO ACID-SCHI BASES
Cited by: 160
Year: 2003

πŸ” Synthesis and biological activity of new cycloalkylthiophene-Schiff bases and their Cr (III) and Zn (II) complexes
Cited by: 57
Year: 2010

πŸ” Synthesis, potentiometric and antimicrobial activity studies on 2-pyridinilidene-DL-amino acids and their complexes
Cited by: 55
Year: 2003

πŸ” Structural, electrochemical and optical properties of hydrothermally synthesized transition metal oxide (Co3O4, NiO, CuO) nanoflowers
Cited by: 46
Year: 2020

πŸ” Synthesis of Some Polymer‐Metal Complexes and Elucidation of their Structures
Cited by: 46
Year: 2006

πŸ” Spectroscopic characterization of novel d-amino acid-Schiff bases and their Cr(III) and Ni(II) complexes as antimicrobial agents
Cited by: 37
Year: 2013

πŸ” Preparation of carbon paste electrodes including poly (styrene) attached glycine–Pt (IV) for amperometric detection of glucose
Cited by: 34
Year: 2014

πŸ” Nanospheres caped Pt (II) and Pt (IV): synthesis and evaluation as antimicrobial and Antifungal Agent
Cited by: 31
Year: 2017

πŸ” Ni (II)-tetrahedral complexes: Characterization, antimicrobial properties, theoretical studies and a new family of charge-transfer transitions
Cited by: 31
Year: 2013

πŸ” Some novel amino acid-schiff bases and their complexes synthesis, characterization, solid state conductivity behaviors and potentiometric studies
Cited by: 29
Year: 2004

πŸ” Synthesis, antimicrobial and antimutagenic effects of novel polymeric-Schiff bases including indol
Cited by: 27
Year: 2019

πŸ” Polystyrene attached Pt (IV)–azomethine, synthesis and immobilization of glucose oxidase enzyme
Cited by: 27
Year: 2012

πŸ” Synthesis, potentiometric and antimicrobial activity studies on DL-amino acids-Schiff bases and their complexes
Cited by: 27

 

Victor Chigozie | Pharmaceutical Biotechnology | Best Researcher Award

Published on by Global Academic Awards

Dr. Victor Chigozie | Pharmaceutical Biotechnology | Best Researcher Award

Dr. Victor Chigozie, David Umahi Federal University of Health Sciences, Nigeria

Dr. Chigozie Victor Uchenna is a Lecturer I at David Umahi Federal University of Health Sciences, Uburu, Ebonyi State, Nigeria, where he also serves as the acting head of the Department of Pharmaceutical Microbiology and Biotechnology. He completed his Ph.D. in Pharmaceutical Biotechnology from Nnamdi Azikiwe University, Awka, where his research focused on the identification and bioactivities of secondary metabolites from fungi. Dr. Chigozie has extensive teaching and research experience, including in pharmaceutical microbiology, biotechnology, and the study of natural products. His key research areas include bioactive compounds, antimicrobial agents, and cancer therapeutics.

Publication Profile

Orcid

Google Scholar

Educational Background πŸŽ“

Dr. Victor Chigozie holds a Ph.D. in Pharmaceutical Biotechnology from Nnamdi Azikiwe University, Awka, Nigeria, where his research focused on the identification and bioactivities of secondary metabolites from Aspergillus species and Daldinia eschscholtzii found in Mangifera indica and Musa paradisiaca leaves. He graduated with first-class honors (4.69/5.0) in 2021. Dr. Chigozie also completed an M.Sc. in Pharmaceutical Microbiology and Biotechnology at the same university, with research on the quality assessment of tetanus toxoid brands in southeastern Nigeria’s markets, publishing his findings. He holds a B.Sc. in Applied Microbiology with second-class honors (4.12/5.0) and a Senior School Certificate with Upper Credit. πŸŽ“πŸ“šπŸ”¬

 

Professional Experience πŸ§‘β€πŸ”¬

Dr. Victor Chigozie has held several key positions in academic and government institutions, contributing significantly to research and development. As a Lecturer I and Acting Head of Pharmaceutical Microbiology and Biotechnology at David Umahi Federal University of Health Sciences, Ebonyi State, he has been instrumental in coordinating classes, practicals, and research, especially in natural products and pharmaceutical biotechnology. He set up a BSL-2 lab and contributed to the development of practical manuals.

Teaching Experience πŸ“šπŸ‘¨β€πŸ«

Dr. Victor Chigozie has a rich teaching history, contributing extensively to pharmaceutical sciences. At David Umahi Federal University of Health Sciences, Uburu, he has taught several courses, including Introductory Pharmaceutical Microbiology (PHM 201) and Molecular Biology (PHM 202) since 2022, alongside practicals in both subjects. His expertise extends to Pharmaceutical Microbiology I (PHM 301), Aseptic Processes and Sterilization Technology (PHM 302), and Bioinformatics, Pharmacogenetics, and Pharmacogenomics (PHM 382), all of which he began teaching in 2024. Additionally, he teaches courses on integrated pharmacotherapy and sterile product technology.

 

Awards and Recognitions πŸ†πŸŽ–οΈ

Dr. Victor Chigozie has received numerous prestigious awards for his contributions to pharmaceutical microbiology and biotechnology. Notably, he was named Top Cite Author by Wiley Publishers for 2022-2023. He also received a Travel Grant Award from the Wuhan Institute of Virology (2023) and the National Foundation for Infectious Diseases (2012). Dr. Chigozie was honored with the Ph.D. Award for being the top of his class at Nnamdi Azikiwe University (2021). Additionally, he won the CBN-NYSC-NDE Venture Prize Competition during his NYSC service for the Best Business Proposal (2010). πŸ…πŸ“š

 

Research Focus

 

Dr. Victor Chigozie’s research spans a wide array of topics in pharmaceutical microbiology, biotechnology, and public health. His work includes antibiotic resistance, exploring emerging strategies to tackle global health challenges. He has contributed significantly to bioactive compounds and endophytic fungi, studying their potential in antimicrobial, anti-inflammatory, and analgesic activities. His research also delves into pharmacovigilance, self-medication practices, and the role of community pharmacies in healthcare systems. Additionally, Dr. Chigozie investigates biosecurity, biosafety, and differentiated care models for diseases like HIV/AIDS. His focus on indigenous knowledge in managing emerging infectious diseases in Africa highlights his commitment to improving health through both modern science and traditional insights. πŸŒ±πŸ’Š

 

Publication Top Notes

  • Antibiotic resistance: The challenges and some emerging strategies for tackling a global menace – D Chinemerem Nwobodo, MC Ugwu, C Oliseloke Anie, MTS Al‐Ouqaili, … (Cited by: 405, Year: 2022) 🦠
  • Evaluation of the analgesic, anti-inflammatory and antimicrobial activities of leaf extracts of Breynia nivosa – FA Onyegbule, IO Ilouno, PM Eze, CC Abba, VU Chigozie (Cited by: 19, Year: 2014) 🌿
  • Isolation, identification, and evaluation of biological activities of Daldinia eschscholtzii, an endophytic fungus isolated from the leaves of Musa paradisiaca – V Chigozie, M Okezie, E Ajaegbu, F Okoye, C Esimone (Cited by: 13, Year: 2020) 🍌
  • Bioactivities and HPLC analysis of secondary metabolites of a morphologically identified endophytic Aspergillus fungus isolated from Mangifera indica – VU Chigozie, MU Okezie, EE Ajaegbu, FB Okoye, CO Esimone (Cited by: 11, Year: 2022) πŸ₯­
  • Larvicidal and synergistic potentials of some plant extracts against Aedes aegypti – GT Onah, EE Ajaegbu, CC Ezeagha, VU Chigozie, AM Bello, P Chinelo (Cited by: 3, Year: 2022) 🦟
  • Practice, Risk Perception, and Correlates of Self-Medication Among Pregnant Women in Awka – OOB Anthony Maduka, Daniel U. Eze, Victor U. Chigozie (Cited by: 2, Year: 2024) πŸ’Š
  • Community Pharmacies, Extent of Services, and Preparedness for Primary Health Care Policy Implementation in Nigeria from 1980 to 2022: A Narrative Review – M Maureen, DU Eze, OC Clementina, N Monica, VU Chigozie, O Brian O (Cited by: 1, Year: 2024) πŸ₯
  • Quality Assessment of Some Brands of Tetanus Toxoids Marketed in Open Markets in South-Eastern Nigeria – VU Chigozie, PM Eze, CR Chukwunwejim, CC Abba, CS Nworu, … (Cited by: 1, Year: 2014) πŸ’‰
  • Identification of Some Bioactive Compounds from Camellia sinensis as Possible Inhibitors of human epidermal growth factor receptor 2 (HER2) – LN Ebenyi, CBG Egwuom, EM Halilu, AP Obialor, TO Johnson, … (Year: 2024) 🍡
  • Antioxidative, anti-androgenic, and inhibitory activities of ethanolic extract of Annona muricata leaf on sex hormones-induced benign prostate hyperplasia through in vivo and … – DDCBA Lilian N. Ebenyi, Victor U. Chigozie (Year: 2024) πŸƒ

Gopal Natesan | Medicinal Chemistry | Best Researcher Award

Published on by Global Academic Awards

Prof Dr. Gopal Natesan | Medicinal Chemistry | Best Researcher Award

Prof Dr. Gopal Natesan, Institute of Pharmacy, Nirma University, India

Prof. Dr. Gopal Natesan is a distinguished academic and researcher in pharmaceutical chemistry, currently serving as Professor & Director at the Institute of Pharmacy, Nirma University, India. He holds a Ph.D. from Hamdard University and an MBA from MAHSA University. His research focuses on the synthesis of biologically active compounds and pharmacological evaluations. Dr. Natesan has received numerous accolades, including the “Most Trusted & Innovative Researcher in Asia” award in 2023 and the “Outstanding Scientist Award” in 2022. With a strong industrial background, he promotes research innovation and academic excellence. πŸ§ͺπŸ“š

Publication profile

Google Scholar

Educational Qualifications

Prof. Dr. Gopal Natesan boasts an impressive educational background. He earned his Ph.D. in Pharmaceutical Chemistry from Hamdard University in 2001. He also holds an M. Pharmacy from JSS College of Pharmacy (1996) and a B. Pharmacy from JKK Nataraja College of Pharmacy (1993), both affiliated with The Tamilnadu Dr. MGR Medical University. In 2016, he completed a Post Graduate Certificate in Teaching & Learning at Anglia Ruskin University, UK, and became a Fellow of The Higher Education Academy. Most recently, he obtained an MBA from MAHSA University in 2022. πŸ“šπŸ”¬

 

Honors & Awards

Prof. Dr. Gopal Natesan has received numerous prestigious awards for his contributions to pharmaceutical science and education. In 2023, he was honored as the “Most Trusted & Innovative Researcher in Asia” at the ASIA-GCC Awards. His accolades include the “Outstanding Scientist Award” in 2022 and the “Edward Kennedy Memorial Award” in 2017. He has also received multiple best presentation and paper awards at international conferences, reflecting his commitment to excellence in research. Additionally, he was recognized with a Vice-Chancellor Award for outstanding performance in his MBA program, showcasing his academic prowess. πŸŒŸπŸŽ“

 

Employment History

Prof. Dr. Gopal Natesan has served as Professor and Director at the Institute of Pharmacy, Nirma University, Ahmedabad, India. In this role, he manages operational activities, ensuring efficient administration and resource utilization. He oversees academic programs, maintaining high standards in teaching and curriculum development. Dr. Natesan is dedicated to faculty development, fostering continuous learning and research engagement. He enhances student experiences through support services and extracurricular activities while ensuring quality assurance through compliance with academic standards. Additionally, he promotes research innovation by securing grants and encouraging collaborations with industry and academia. πŸŒŸπŸ”¬

Industrial Experience

Prof. Dr. Gopal Natesan has valuable industrial experience in the pharmaceutical sector. From November 2000 to January 2002, he worked as a Research Scientist at Ranbaxy Research Laboratory in Gurgoan, New Delhi, where he contributed to innovative pharmaceutical research. Following this, he served as a Research Associate at Orchid Chemicals & Pharmaceuticals Ltd in Chennai from January 2002 to February 2004. In these roles, he developed essential skills in research methodologies and project management, further enhancing his expertise in medicinal chemistry and pharmaceutical sciences. His industrial background complements his academic leadership, bridging theory and practice. πŸ’Όβœ¨

 

Research Interests

Prof. Dr. Gopal Natesan specializes in medicinal chemistry, focusing on the synthesis and characterization of biologically active new chemical entities with five or six-member heterocyclic ring systems. His research includes the pharmacological evaluation of synthesized compounds, ensuring their potential therapeutic applications. Additionally, he is dedicated to the isolation and characterization of active constituents from plant sources, highlighting the importance of natural products in drug discovery. Dr. Natesan also explores pharmaceutical marketing management, integrating scientific research with practical applications in the pharmaceutical industry. πŸŒ±πŸ’Š

 

Publication Top Notes Β 

 

  • Hepatoprotective activity of Clerodendrum inerme against CCl4 induced hepatic injury in rats – Cited by: 85, Year: 2008 πŸ“„
  • Simultaneous estimation of paracetamol and aceclofenac in combined dosage forms by RP-HPLC method – Cited by: 44, Year: 2007 πŸ’Š
  • Synthesis and Antibacterial Activity of Some Imidazole‐5‐(4H)one Derivatives – Cited by: 32, Year: 2005 🦠
  • Synthesis, characterization and antimicrobial activity of some novel Schiff and Mannich bases of isatin – Cited by: 22, Year: 2014 ✨
  • Antipyretic and analgesic effects of the aqueous extracts of Prosopis cineraria – Cited by: 22, Year: 2011 🌿
  • Quantitative estimation of lopinavir and ritonavir in tablets by RP-HPLC method – Cited by: 19, Year: 2012 πŸ’Š
  • Simultaneous estimation of levocetirizine, ambroxol, phenylpropanolamine and paracetamol in combined dosage forms by RP-HPLC method – Cited by: 17, Year: 2006 πŸ“Š
  • Anti-inflammatory activity of newly synthesised N-[4’-Oxo-2’-(substituted aryl/heteryl)-thiazolidin-3’-yl]-3-carboxamido-2H-chromen-2-one derivatives – Cited by: 15, Year: 2011 πŸ”
  • UV-Spectrophotometric Determination of Esomeprazole in tablet dosage forms – Cited by: 14, Year: 2007 πŸ’‘
  • Effect of pollen substitute and two queen system on royal jelly production in Apis Mellifera L – Cited by: 13, Year: 1996 🐝
  • A validated HPTLC method for the estimation of donepezil HCL in bulk and its tablet dosage form – Cited by: 12, Year: 2011 βœ”οΈ
  • Synthesis and anticonvulsant activity of new 2-(substituted aryl/heteryl)-3-(substituted arylidenimino)-6, 8-dibromo-1, 2, 3, 4-tetrahydroquinazolin-4 (3H)-one derivatives – Cited by: 12, Year: 2006 ⚑
  • Synthesis and pharmacological evaluation of some indanone-3-acetic acid derivatives – Cited by: 11, Year: 2006 πŸ“ˆ
  • UV spectrophotometric determination of famciclovir – Cited by: 10, Year: 2007 πŸ“Š
  • Simultaneous determination of lafutadine and domperidone in capsule by high performance liquid chromatography – Cited by: 9, Year: 2012 πŸ’Ό